Wholesale Trade / Wholesale – Drugs & Drug Proprietaries
Cosmos Health Inc.
COSM
$0.35
+$0.04 (+11.23%)
Price as of Oct 9, 2026 17:19 UTC
21 M
Market Cap (Micro Cap)
Nov 12
Next Earnings
Technical Signals
as of Oct 7
Mixed
3 of 7
Trend
- Above 20-day average $0.34
- Above 50-day average $0.30
- Above 200-day average $0.35 · -8.4%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 20d ago
Volume
- Below-average volume 1.1x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for COSM options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
21 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Siokas Grigorios | Buy | 349,825 | $70,000 | +54.9% | |
| Jul 29, 2026 | Terzis Georgios | Grant | 328,407 | $60,000 | +69.7% | |
| Jul 29, 2026 | Siokas Grigorios | Buy | 766,284 | $140,000 | +69.7% | |
| Jun 16, 2026 | Terzis Georgios | Buy | 168,135 | $42,000 | +24.1% | |
| Jun 11, 2026 | Siokas Grigorios | Buy | 218,447 | $45,000 | +50.5% | |
| Jun 10, 2026 | Siokas Grigorios | Buy | 701,447 | $160,000 | +35.9% | |
| May 19, 2026 | Hoidas John James | Grant | 20,000 | $5,660 | +9.5% | |
| May 19, 2026 | Demetriades Demetrios G. | Conversion | 20,000 | $0 | +10.7% | |
| May 19, 2026 | Siokas Grigorios | Grant | 2,350,000 | $665,050 | +9.5% | |
| May 19, 2026 | Siokas Grigorios | Conversion | 2,350,000 | $0 | +10.7% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 24, 2026 | Q2 2026 | $0.01 | |||
| Aug 17, 2026 | Q2 2026 | $0.01 | |||
| Mar 31, 2026 | Q1 2026 | -$0.01 | -$0.06 | -488.2% | Miss |
| Dec 31, 2025 | Q4 2025 | -$0.04 | -$0.31 | -659.8% | Miss |
| Sep 30, 2024 | Q3 2024 | -$0.11 | -$0.45 | -301.1% | Miss |
| Jun 30, 2024 | Q2 2024 | -$0.14 | -$0.15 | -5.0% | Miss |
Track COSM with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for COSM and your entire portfolio.